Hypoxia determines survival outcomes of bacterial infection through HIF-1α–dependent reprogramming of leukocyte metabolism

AAR Thompson, RS Dickinson, F Murphy… - Science …, 2017 - science.org
AAR Thompson, RS Dickinson, F Murphy, JP Thomson, HM Marriott, A Tavares, J Willson…
Science immunology, 2017science.org
Hypoxia and bacterial infection frequently coexist, in both acute and chronic clinical settings,
and typically result in adverse clinical outcomes. To ameliorate this morbidity, we
investigated the interaction between hypoxia and the host response. In the context of acute
hypoxia, both Staphylococcus aureus and Streptococcus pneumoniae infections rapidly
induced progressive neutrophil-mediated morbidity and mortality, with associated
hypothermia and cardiovascular compromise. Preconditioning animals through longer …
Hypoxia and bacterial infection frequently coexist, in both acute and chronic clinical settings, and typically result in adverse clinical outcomes. To ameliorate this morbidity, we investigated the interaction between hypoxia and the host response. In the context of acute hypoxia, both Staphylococcus aureus and Streptococcus pneumoniae infections rapidly induced progressive neutrophil-mediated morbidity and mortality, with associated hypothermia and cardiovascular compromise. Preconditioning animals through longer exposures to hypoxia, before infection, prevented these pathophysiological responses and profoundly dampened the transcriptome of circulating leukocytes. Specifically, perturbation of hypoxia-inducible factor (HIF) pathway and glycolysis genes by hypoxic preconditioning was associated with reduced leukocyte glucose utilization, resulting in systemic rescue from a global negative energy state and myocardial protection. Thus, we demonstrate that hypoxia preconditions the innate immune response and determines survival outcomes after bacterial infection through suppression of HIF-1α and neutrophil metabolism. In the context of systemic or tissue hypoxia, therapies that target the host response could improve infection-associated morbidity and mortality.
AAAS